Monitoring Agency report for the Quarter and Financial Year ended on 31st March,2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Ltd, the monitoring agency for Valplast's Rs. 28.09 crore IPO (September-October 2025), has flagged material deviations in fund utilization for Q4FY26. The company spent Rs. 0.18 crore on contractor payments and Rs. 1.36 crore on vendor payments for materials like cement, steel, and cables without obtaining board resolution — a compliance violation. Capital expenditure of Rs. 4.95 crore for machinery purchase remains entirely unutilized (Rs. 0 spent) and is delayed beyond the FY26 deadline without regulatory approval for extension. Working capital (Rs. 14 crore) and issue expenses (Rs. 3.11 crore) were fully deployed. Rs. 5.06 crore remains unutilized in a bank account. The monitoring agency also noted fund commingling in current accounts, restricting clear tracking of end-use of IPO proceeds.
The flagged deviations — particularly unauthorized spending and delayed capex deployment — signal weak corporate governance and potential regulatory non-compliance. This raises red flags for investors regarding how IPO funds are being managed and whether the company's stated growth plans are on track.